CD44v6-derived peptides for treating pancreatic cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9586993
APP PUB NO 20150166607A1
SERIAL NO

14407244

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds, pharmaceutical compositions and methods for treating different forms of pancreatic cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AMCURE GMBH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Matzke, Alexandra Dettenheim, DE 8 5
Orian-Rousseau, Veronique Rittershoffen, FR 4 0
Ponta, Helmut Graben-Neudorf, DE 17 43

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 7, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 7, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00